Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer? - Morgans AK; Touya M; El-Chaar N; ElSouda D; Mucha L; Ramaswamy K; Adejumo KL; Schuler T; Sharpe J; Feinberg B; Asgarisabet P; Pathak P; et al. (Clinical genitourinary cancer, 2026)